Crystal structure of 1-(4-((benzo[d][1,3]dioxol-5-yloxy)methyl)phenethyl)-4-(3-chlorophenyl)piperazin-1-ium chloride, C26H28Cl2N2O3

被引：3
|
作者：
Chen, Hong [1 ]
Jia, Hui-Xia [1 ]
Xu, Qi-Tai [1 ]
机构：
[1] Luoyang Normal Univ, Coll Food & Drug, Luoyang 471934, Henan, Peoples R China
来源：
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2018年 / 233卷 / 01期
关键词：
D O I：
10.1515/ncrs-2017-0196
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
C26H28Cl2N2O3, monoclinic, P2(1)/c (no. 14), a = 13.422(3) angstrom, b = 7.0011(14) angstrom, c = 26.249(5) angstrom, beta = 101.06(3)degrees, V = 2420.8(9) angstrom(3), Z = 4, R-gt(F)= 0.0516, wR(ref)(F-2)= 0.1370, T = 296 K.
引用
收藏
页码：107 / 109
页数：3
相关论文
共 50 条
  • [31] Crystal structure of 2-(4-(2-(4-(2-fluorophenyl)piperazin-1-yl)ethyl)benzyl) benzo[d]isothiazol-3(2H)-one 1,1-dioxide, C26H26FN3O3S - a saccharin dervative
    Chen, Hong
    Jia, Hui-Xia
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2018, 233 (01): : 111 - 113
  • [32] Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(Benzo[1,3] dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human
    Kalgutkar, Amit S.
    Feng, Bo
    Nguyen, Hang T.
    Frederick, Kosea S.
    Campbell, Scott D.
    Hatch, Heather L.
    Bi, Yi-An
    Kazolias, Diana C.
    Davidson, Ralph E.
    Mireles, Rouchelle J.
    Duignan, David B.
    Choo, Edna F.
    Zhao, Sabrina X.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (11) : 2111 - 2118
  • [33] Crystal structure of 1-[2-[6-(4-methoxyphenyl)-3(2H)-pyridazinone-2-yl]acetyl]-4-(3-chlorophenyl)piperazine, C23H23ClN4O3
    Ingeç, SK
    Soylu, H
    Engin, K
    Dogruer, DS
    Sahin, MF
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2000, 215 (03): : 433 - 434
  • [34] The crystal structure of 1-methyl-1H-pyrazol-2-ium nitrate, C4H7O3N3
    Chen Cong
    Xiao Yun
    Li Chong
    Chen LiZhen
    Wang Jianlong
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2022, 237 (02): : 237 - 238
  • [35] 3-[4-(4-Fluorophenyl)piperazin-1-ylmethyl]-5-methyl-1,3-benzoxazol-2(3H)-one and 3-[4-(2-fluorophenyl)piperazin-1-ylmethyl]-5-methyl-1,3-benzoxazol-2 (3H)-one
    Köysal, Y
    Isik, S
    Köksal, M
    Erdogan, H
    Gokhan, N
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2004, 60 : O232 - O234
  • [36] Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent
    Kumari, Shikha
    Mishra, Chandra Bhushan
    Tiwari, Manisha
    PHARMACOLOGICAL REPORTS, 2016, 68 (02) : 250 - 258
  • [37] Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent
    Shikha Kumari
    Chandra Bhushan Mishra
    Manisha Tiwari
    Pharmacological Reports, 2016, 68 : 250 - 258
  • [38] Crystal structure of 1-(p-tolylphenyl)-4-(2-furoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O3
    Wu, Qiong
    Huang, Zhen-Yu
    Liu, Yun-Xin
    Zhang, Heng-Qiang
    Jin, Tong-Yin
    Xue, Yu-Na
    Liu, Chang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (02): : 327 - 329
  • [39] The crystal structure of the salt: 4-((1,3-dioxoisoindolin-2-yl)carbamoyl)pyridine-1-ium 2-carboxybenzoate, C14H10N3O3•C8H5O4
    Smith, Mark G.
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2023, : 1227 - 1228
  • [40] Crystal Structure of 4,6-Dimethyl-5-(3-chlorophenyl)-2-{[4-(3,4-dichlorophenyl)1-piperazinyl]methyl}-pyrrolo[3,4-c]pyrrole-1,3(2H,5H)-dione
    Redzicka, Aleksandra
    Szczukowski, Lukasz
    Kochel, Andrzej
    X-RAY STRUCTURE ANALYSIS ONLINE, 2018, 34 : 55 - 56
12345